Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy

@inproceedings{Stnder2010TargetingTN,
  title={Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy},
  author={Sonja St{\"a}nder and Dorothee Siepmann and Ilka Herrgott and Cord H Sunderk{\"o}tter and Thomas Anton Luger},
  booktitle={PloS one},
  year={2010}
}
BACKGROUND Chronic pruritus is a global clinical problem with a high impact on the quality of life and lack of specific therapies. It is an excruciating and frequent symptom of e.g. uncurable renal, liver and skin diseases which often does not respond to conventional treatment with e.g. antihistamines. Therefore antipruritic therapies which target physiological mechanisms of pruritus need to be developed. Substance P (SP) is a major mediator of pruritus. As it binds to the neurokinin receptor 1… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS
69 Citations
30 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 69 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Neurobiology of Pruritus

  • A Ikoma, M Steinhoff, S Ständer, G Yosipovitch, M Schmelz
  • Nature Reviews Neuroscience
  • 2006
Highly Influential
4 Excerpts

The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study

  • G Tessari, C Dalle Vedove, C Loschiavo, N Tessitore, C Rugiu
  • J Nephrol
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…